'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Acute Promyelocytic Leukemia to Oncology Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Acute Promyelocytic Leukemia to Oncology Clinical Trials 20
Clinical Trials by Phase in E7 Countries 22
Clinical Trials in E7 Countries by Trial Status 23
Clinical Trials by Phase 24
In Progress Trials by Phase 25
Clinical Trials by Trial Status 26
Clinical Trials by End Point Status 27
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Acute Promyelocytic Leukemia Therapeutics Clinical Trials 32
Prominent Drugs 34
Clinical Trial Profile Snapshots 35
Appendix 126
Abbreviations 126
Definitions 126
Research Methodology 127
Secondary Research 127
About GlobalData 127
Contact Us 128
Disclaimer 128
Source 128
List of Tables
Acute Promyelocytic Leukemia Therapeutics, Global, Clinical Trials by Region, 2018* 7
Acute Promyelocytic Leukemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Acute Promyelocytic Leukemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Acute Promyelocytic Leukemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Acute Promyelocytic Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Acute Promyelocytic Leukemia Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Acute Promyelocytic Leukemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14
Acute Promyelocytic Leukemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 15
Proportion of Acute Promyelocytic Leukemia to Oncology Clinical Trials, G7 Countries (%), 2018* 17
Acute Promyelocytic Leukemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Acute Promyelocytic Leukemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Acute Promyelocytic Leukemia to Oncology Clinical Trials, E7 Countries (%), 2018* 21
Acute Promyelocytic Leukemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 22
Acute Promyelocytic Leukemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 23
Acute Promyelocytic Leukemia Therapeutics, Global, Clinical Trials by Phase, 2018* 24
Acute Promyelocytic Leukemia Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 25
Acute Promyelocytic Leukemia Therapeutics, Global, Clinical Trials by Trial Status, 2018* 26
Acute Promyelocytic Leukemia Therapeutics Clinical Trials, Global, by End Point Status, 2018* 27
Acute Promyelocytic Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 28
Acute Promyelocytic Leukemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 29
Acute Promyelocytic Leukemia Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 31
Acute Promyelocytic Leukemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 33
Acute Promyelocytic Leukemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 34
List of Figures
Acute Promyelocytic Leukemia Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Acute Promyelocytic Leukemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Acute Promyelocytic Leukemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Acute Promyelocytic Leukemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Acute Promyelocytic Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Acute Promyelocytic Leukemia Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Acute Promyelocytic Leukemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 14
Acute Promyelocytic Leukemia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 15
Proportion of Acute Promyelocytic Leukemia to Oncology Clinical Trials, G7 Countries (%), 2018* 16
Acute Promyelocytic Leukemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Acute Promyelocytic Leukemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Acute Promyelocytic Leukemia to Oncology Clinical Trials, E7 Countries (%), 2018* 20
Acute Promyelocytic Leukemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 22
Acute Promyelocytic Leukemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 23
Acute Promyelocytic Leukemia Therapeutics, Global, Clinical Trials by Phase (%), 2018* 24
Acute Promyelocytic Leukemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 25
Acute Promyelocytic Leukemia Therapeutics, Global, Clinical Trials by Trial Status, 2018* 26
Acute Promyelocytic Leukemia Therapeutics Clinical Trials, Global, by End Point Status, 2018* 27
Acute Promyelocytic Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 28
Acute Promyelocytic Leukemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 29
Acute Promyelocytic Leukemia Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 30
Acute Promyelocytic Leukemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 32
Acute Promyelocytic Leukemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 34
GlobalData Methodology 127